The global pharmaceutical market is witnessing a significant shift towards liquid oral dosage forms. As the demand for pediatric and geriatric-friendly medications surges, the industry is evolving from standard mass production to high-precision, custom liquid formulation. Today, "Liquid Orals" are not just limited to syrups; they encompass advanced emulsions, suspensions, and nano-liquids used in high-tech healthcare.
Global procurement demands have become increasingly rigorous. Modern enterprises in Europe, North America, and Southeast Asia are seeking manufacturing partners who can offer not just products, but complete turnkey systems with high automation and GMP compliance.
Located in the tech-hub of Hangzhou, Hangzhou Jeci Biochem Technology Co., Ltd. stands as a beacon of quality in the Chinese biochemical sector. We are committed to the sales of active pharmaceutical ingredients (APIs), pharmaceutical intermediates, nutritional products, and food additives. Our core strength lies in our integrated approach: combining cooperative R&D, custom manufacturing, and global logistics service.
In China, we have built a powerful collaborative network. We work in depth with new drug research institutes and multiple custom processing plants. Our domestic sales channels are robust, offering product application support, technology transfer, and exclusive agency services. We don't just supply chemicals; we provide factory quality management system certification consulting to ensure our partners reach global standards.
The "Industry 4.0" revolution is reshaping liquid oral manufacturing. We are seeing a massive trend towards Automated Liquid Formulation Systems. These systems utilize AI to manage precision dosing, ensuring that every batch of liquid oral medicine meets exact concentration levels, reducing waste and increasing safety.
Our infrastructure is designed for scale and precision. We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization.
Advanced Manufacturing Advantages:
For our company's main product intermediates, we maximize our technical advantages to meet the most stringent customer requirements. Our production lines are equipped with the latest Marya aseptic vial filling technology, ensuring that every drop of liquid is handled in a contamination-free environment.
The international market, including India, Southeast Asia, South Korea, and Japan, looks to China for several key reasons:
Massive raw material supply chains reduce the overall production cost without sacrificing purity.
Access to advanced R&D for complex formulations like Astragalus Polysaccharide or Shuanghuanglian oral liquids.
Agile manufacturing systems that allow for rapid prototyping and scale-up.
Furthermore, Hangzhou Jeci provides comprehensive support for overseas companies entering the Chinese market, including product registration, regulatory consulting, and sales channel expansion.
SJ medical
